Sign in

You're signed outSign in or to get full access.

Navid Mahmoodzadegan

Navid Mahmoodzadegan

Chief Executive Officer at Moelis &Moelis &
CEO
Executive
Board

About Navid Mahmoodzadegan

Navid Mahmoodzadegan is Co‑Founder and Chief Executive Officer of Moelis & Company (effective October 1, 2025) and serves on the Board of Directors; he previously was Co‑President since September 2015 and a Managing Director since 2007. He is 55, holds an A.B. with Highest Distinction from the University of Michigan (Phi Beta Kappa) and a J.D. from Harvard Law School, magna cum laude . 2024 firm performance considered by the Compensation Committee included adjusted revenues of $1.2 billion and a 37% one‑year TSR, with long‑term returns of 234% over five years and 525% since IPO; in 2025 Q3, revenue rose to $356.9 million GAAP and adjusted pre‑tax margin improved to 22.2% versus 9.5% YoY, underscoring momentum into his CEO tenure . Management notes quarterly results can be volatile due to transaction timing, cautioning against extrapolation .

Past Roles

OrganizationRoleYearsStrategic impact
Moelis & CompanyCo‑President; Managing DirectorCo‑President since Sep 2015; MD since 2007 Co‑led global IB business; built Energy and Capital Structure Advisory; led global Media/Telecom/Tech franchise; direct revenue contributions; oversight of risk procedures
UBSGlobal Head of Media Investment Banking; member, IB Americas Exec Committee2001–2007 Led sector franchise; senior leadership within UBS IB Americas
Donaldson, Lufkin & JenretteInvestment banker1995–2001 M&A/sector coverage experience
Irell & ManellaAttorneyEarly career (pre‑1995) Legal training grounding later advisory career

External Roles

OrganizationRoleYearsStrategic impact
Taft SchoolBoard of TrusteesCurrent Education governance and strategy
Carlthorp SchoolBoard Chair, Board of TrusteesPrior service Non‑profit leadership
JumpStart (National Board)DirectorPrior service Education non‑profit oversight

Fixed Compensation

YearBase Salary ($)Cash Bonus ($)Notes
2024400,000 2,130,000 Bonus paid following year; reflects 2024 performance
2023400,000 3,000,000
2022400,000 5,000,000
Employment agreement termKey provisionDetails
Base salary$400,000 annuallySemi‑monthly payroll; reductions only if generally applied to majority of U.S. MDs
Annual incentiveDiscretionaryCommittee‑approved; contingent on firm and individual performance; paid per MD schedule
Benefits/perqsAircraft reimbursementReimbursement for business use of private aircraft; standard benefits/401(k)
EmploymentAt‑willTermination by either party; CEO reports to Board; primary office Los Angeles
Notice180 daysExecutive must provide 180‑day notice to resign; company may waive/put on paid leave

Performance Compensation

YearEquity award typeGrant dateUnits (#)Grant date fair value ($)Vesting / delivery schedule
2025 (for 2024 perf)Deferred LP UnitsFeb 13, 2025184,519 704,520 (CFO example) / 15,522,200 combined for Navid’s awards; note: Navid total includes 184,519 Deferred LP Units + 51,007 Restricted LTI LP Units Deferred units eligible for redemption: 40% on/about Feb 23, 2027; 20% each of Feb 23, 2028–2030
2025 (for 2024 perf)Restricted LTI LP UnitsFeb 13, 202551,007 Included in $15,522,200 total for 2025 grants Time‑vest 33% on each of Feb 23, 2028–2030
2024 (for 2023 perf)Restricted LP UnitsFeb 15, 2024166,526 Included in $9,387,071 2024 stock awards line 40% on Feb 23, 2026; 20% on Feb 23 of 2027–2029
2024 (for 2023 perf)Restricted LTI LP UnitsFeb 15, 20242,744 Included in $154,679 Equal installments on Feb 23, 2028 and Feb 23, 2029
2023 (for 2022 perf)Restricted LP UnitsFeb 2023253,996 Included in 2023 stock awards 40% on Feb 23, 2025; 20% each on Feb 23 of 2026–2028
2022 (for 2021 perf)Restricted LP UnitsFeb 202285,085 Included in 2022 stock awards Equal installments Feb 23 of 2025–2027
2021 (for 2020 perf)Restricted LP UnitsFeb 202160,842 Included in 2021 stock awards Equal installments Feb 23, 2025 and Feb 23, 2026
2019/2020RSUs + dividend equivalentsFeb 2020 grant; dividends accrued39,565 + 17,444 dividend equivalents n/a100% on Feb 23, 2025
2025 CEO Performance Units (one‑time award)Metric / triggerTargetEarned Units (#)Measurement / service vesting
Dividend‑adjusted 20‑day VWAP$86.00150,000 Quarterly measurement; highest VWAP during performance period; time‑vest equal installments on 3rd, 4th, 5th anniversaries of Sept 30, 2025 (Effective Date); linear interpolation between tiers
Dividend‑adjusted 20‑day VWAP$115.00300,000 As above
Dividend‑adjusted 20‑day VWAP$144.00 or greater450,000 As above
Change‑in‑control treatmentPrice paid in transactionTests performance condition at deal price; service condition deemed achieved if employed at change‑in‑control; unvested non‑earned units forfeited
Termination provisionsWithout Cause / Good ReasonEligible to vest at greater of earned units to date or 225,000 earned units (subject to performance achievement) with continued vesting per schedule, contingent on no “Detrimental Activities”
Annual incentive performance framework (qualitative)WeightingTargetActualPayout determination
Firmwide adjusted revenues, operating margins, adjusted net income, TSR; strategic initiatives; peer benchmarkingDiscretionary (no explicit weights disclosed) Not disclosed 2024 highlights: adjusted revenues ~$1.2B; 37% one‑year TSR; long‑term returns 234% (5‑yr) and 525% since IPO; peer group used for benchmarking (EVR, HLI, LAZ, PWP, PJT) Committee discretion; equity allocation emphasized; CEO incentive pay delivered ~100% in equity

Equity Ownership & Alignment

ItemAmountNotes
Beneficial ownership – Class A shares197,602; ~0.3% of Class AAs of April 9, 2025; excludes LP Units/RSUs not yet delivered
Class B shares0Partner Holdings (controlled by Ken Moelis) holds all Class B; 37% voting power
Unvested stock awards (units)735,853As of 12/31/2024; market value $54,364,805 at $73.88 per share
Equity incentive units unearned30,555Payout value $2,257,373 (market/payout)
  • Ownership guidelines and alignment: NEOs own equity >5x base salaries; multi‑year vesting/deferral (five‑year schedules) designed to align and promote retention; hedging and pledging of company stock are prohibited; clawback policy complies with SEC/NYSE rules .
  • Insider selling pressure: Significant scheduled deliveries/vesting occur on Feb 23 each year (2025–2030) across legacy Restricted LP Units and RSUs; 2025 grants deliver starting 2027; CEO Performance Units vest on 3rd/4th/5th anniversaries of Sept 30, 2025 if price hurdles are achieved .

Employment Terms

ProvisionDetail
Contract typeAt‑will; CEO, reports to Board; Effective Date Oct 1, 2025; LA office
Base salary$400,000; semi‑monthly
Annual bonusDiscretionary; performance‑based; Committee approval
Non‑competeDuring employment; if Executive resigns or terminated for Cause, 90 days post‑termination; passive stakes up to 1% permitted with notice
Non‑solicit (clients)12 months post‑termination; prohibits solicitation/interference
Non‑solicit (employees)12 months post‑termination
Notice to resign180 days; company may waive/place on paid leave
Aircraft reimbursementBusiness use reimbursed
Clawback & insider tradingNYSE‑required clawback; hedging and pledging prohibited per policy
Section 409A, law & arbitrationSection 409A compliance; Delaware law; arbitration per partnership agreement

Board Governance

  • Board service history: Director April 2014–April 2021; rejoined Board effective October 1, 2025 with transition to CEO .
  • Committee roles: MC’s Audit, Compensation, and Nominating & Corporate Governance Committees are entirely independent; current members are independent directors (Mirrer, Shropshire, Worrell); as an executive director, Navid is not described as serving on these committees .
  • Independence and dual‑role implications: As CEO and director, Navid is not independent under NYSE standards; firm has a majority‑independent Board and a Lead Independent Director to balance governance; Chair role is held by Ken Moelis (Executive Chairman), mitigating CEO/Chair concentration concerns .
  • Voting control context: Partner Holdings (controlled by Ken Moelis) holds Class B shares with 10:1 voting; company is no longer a “controlled company” and complies with NYSE independence requirements; Partner Holdings retains certain nomination rights subject to independence constraints .

Multi‑Year Compensation Summary (NEO – Navid Mahmoodzadegan)

YearSalary ($)Cash Bonus ($)Stock Awards ($)All Other ($)Total ($)
2024400,000 2,130,000 9,541,750 27,177 12,098,927
2023400,000 3,000,000 13,554,171 45,300 16,999,471
2022400,000 5,000,000 9,960,423 57,856 15,418,279

Performance & Track Record

  • 2024: Compensation decisions considered adjusted revenues of ~$1.2B, firmwide execution of strategic investments, and 37% annual TSR; peer benchmarking against boutique banks guided committee judgment without fixed targets .
  • 2025 YTD: Q3 GAAP revenues $356.9M; nine months GAAP revenues $1,028.9M; adjusted pre‑tax margin Q3 2025 22.2% vs 9.5% prior year; dividend declared $0.65/share; buybacks of 0.2M shares for $14.5M; strong cash/short‑term investments $619.9M, no debt .
  • Volatility caution: Management highlights quarterly fluctuations from transaction timing; non‑GAAP reconciliations provided .

Compensation Structure Analysis

  • Equity‑heavy pay mix with five‑year vesting/deferral longer than peers; CEO’s 2024 incentive delivered ~100% in equity, reinforcing long‑term alignment .
  • 2025 CEO Performance Units add explicit stock price hurdles with staged time‑vesting, materially tying realized pay to shareholder returns .
  • No option grants; program avoids option‑like instruments; grants occur post‑year with Committee discretion .
  • Clawback policy in place; hedging/pledging prohibited, reducing misalignment risks .

Related Party Transactions and Governance Context

  • Partner Holdings rights and dual‑class structure confer significant influence over major corporate actions and board nominations while the company maintains NYSE majority‑independent board status; mitigants include lead independent director and committee independence .

Equity Ownership & Vesting Schedule Detail (Upcoming Supply Considerations)

Vesting/delivery dateInstrumentUnits (#)Notes
Feb 23, 2025RSUs + dividend equivalents (2019 award)39,565 + 17,444 100% vest
Feb 23, 2025Restricted LP Units (2023 award)253,996: 40% tranche (~101,598) Remaining 20% tranches 2026–2028
Feb 23, 2025–2027Restricted LP Units (2022 award)85,085 over equal installments 2025–2027
Feb 23, 2026–2029Restricted LP Units (2024 award)166,526: 40% in 2026; 20% each 2027–2029
Feb 23, 2028–2029Restricted LTI LP Units (2024 award)2,744: equal installments
Feb 23, 2028–2030Restricted LTI LP Units (2025 award)51,007: 33% annually
Feb 23, 2027–2030Deferred LP Units (2025 award)184,519: 40% in 2027; 20% each 2028–2030 Delivery subject to non‑compete restrictions
Sept 30, 2028–2030 anniversariesCEO Performance Units (2025 award)Earned Units per VWAP tiers (150k/300k/450k) Vest equal installments on 3rd, 4th, 5th anniversaries of Sept 30, 2025, subject to no “Detrimental Activities”

Compensation Peer Group (Benchmarking)

  • Peer set used for comparative performance and pay practices: Evercore, Houlihan Lokey, Lazard, Perella Weinberg Partners, PJT Partners; no explicit percentile/targets; one‑year boutique peers TSR averaged 56% vs MC’s 37%; long‑term returns exceed peers and major indices .

Say‑on‑Pay & Shareholder Feedback

  • Directors elected by majority of votes cast; company emphasizes accountability and independence; general meeting voting requirements summarized; Partner Holdings retains certain rights but company adheres to NYSE independence standards .

Investment Implications

  • Pay‑for‑performance alignment: CEO Performance Units with aggressive VWAP hurdles materially link realized equity to share price outcomes; expect limited near‑term supply from these units, with vesting only after hurdles and time conditions are met .
  • Retention risk mitigants: Five‑year vest/deferral on core equity grants, 180‑day resignation notice, non‑compete/non‑solicit provisions, and clawback reduce flight risk and misalignment; termination rules allow continued vesting only if no “Detrimental Activities” occur .
  • Trading signals: Concentrated vesting dates (Feb 23 annually) and 2027–2030 delivery windows may create episodic supply; monitoring Form 4 filings around these dates is prudent; buybacks and regular dividend ($0.65) support capital return and can offset delivery supply .
  • Governance balance: Executive director role alongside an Executive Chairman within a majority‑independent board structure and robust anti‑hedging/pledging policies are positives; dual‑class control persists via Partner Holdings, warranting continued attention to shareholder rights dynamics .